Omjjara 100/150/200 mg film-coated tablets
*- Company:GlaxoSmithKline (Ireland) Ltd
- Status:No Recent Update
- Legal Category:Product subject to restricted prescription (C)
- Active Ingredient(s):- This medicinal product is subject to additional monitoring. - *Additional information is available within the SPC or upon request to the company 

GlaxoSmithKline (Ireland) Ltd

- Address:12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland
- Telephone:+353 1 495 5000
- Medical Information Direct Line:1 800 244 255
